Order Drugs Now

TEL: 1 866 893 0369
FAX: 1 866 402 4033

Medical News

Subscribe to Newsletter

To get info on the latest products, specials and pharmacy news, please enter your e-mail address:


August 7th, 2009
Insmed Maintains Limited IPLEX Supply for Existing Patients

Biopharmaceutical company Insmed Inc. has publicized that effective immediately, they will halt new patient distribution of Iplex.  They feel it is in the existing patients best interest to maintain supplies at this time for their treatment only.  As a result, at this time, Insmed will not instigate further clinical trials of Iplex.

Because of Merck & Co.‘s purchase of Insmed’s manufacturing facility in March of 2009, Insmed is unable to manufacture the highly complex drug assembly of Iplex.  Any third party manufacturing contracts (if arranged) could not lead to additional production of Iplex for up to 18 months.

Approximately, 70 patients currently receive Iplex, 12 live within the US with the remained distributed around the world.  Insmed is confidant that they are able to supply the existing patients with their share for the next 24 months.

Insmed’s Chairman Dr. Melvin Sharoky states that they “believe it is in the best interest of our patients who currently receive Iplex to ensue that our current limited inventory is conserved in order to maintain their drug supply as long as possible, while allowing the Company time to consider its development options.”


Search for Medication or Types of Conditions



: 0
Total: $0.00

view my cart check out credit cards

Find out how much you can save now!

download order form


Medicine Shoppe Pharmacy
148 #9 31205 Maclure Road
Abbotsford BC, Canada

Ph: 1-866-893-0369
Fax: 1-800-878-7930

Licence J30
Manager: S. Maan


TEL: 1 (866) 893-0369
FAX: 1 (800) 878-7930